|
|
|
|
|
searchin this issue
premium serviceseventsdirectory servicesadvertisingcustomer care |
Archives :: Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals
Displaying 41 - 60 of 414 stories.
April 10, 2009
Sanofi-Aventis (Paris) says its Sanofi-Aventis Mexico (Mexico City) subsidiary has acquired generic pharmaceutical firm Laboratorios Kendrick (Mexico City), for an undisclosed sum...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Sanofi-Aventis-Acquires-Generics-Drugmaker-in-Mexico_18209.html April 10, 2009
Johnson Matthey says it plans to close its prostaglandin active pharmaceutical ingredient (API) facility at Cork, Ireland with the loss of 21 jobs, due to poor demand in the European...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Johnson-Matthey-to-Close-Prostaglandin-API-Facility-in-Ireland_18210.html April 10, 2009
Catalent Pharma Solutions (Somerset, NJ), a contract manufacturer and pharmaceutical services company, says it has sold its Osny, France oral drug manufacturing business to Bavaria...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Catalent-Sells-Osny-Unit_18211.html April 10, 2009
Merck KGaA says it has launched a venture capital fund, called Merck Serono Ventures, to invest in emerging biotechnology companies. The fund aims to support biotech startup companies...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Merck-KGaA-Launches-Fund_18212.html April 3, 2009
Supply chain safety was a major concern at the annual conference of the Drug, Chemical, and Allied Technologies Association (DCAT; Robbinsville, NJ) meeting, held late last month in...http://www.chemweek.com/sections/pharma_and_fine_chemicals/DCAT-Supply-Chain-Safety-High-on-List-of-Concerns_18029.html April 3, 2009
DSM has signed a contract with North China Pharmaceutical Group Corp. (NCPC; Shijiazhuang) to establish three separate joint ventures with NCPC involving nutritional products and...http://www.chemweek.com/sections/pharma_and_fine_chemicals/DSM-to-Invest-in-Anti-Infectives-in-China_18030.html April 3, 2009
Mylan (Canonsburg, PA) says it will purchase the stake in Matrix Laboratories (Secunderabad, India) that it does not already own from minority shareholders for about $133 million...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Mylan-to-Buy-Remainder-of-Matrix-for-$133-Million_18031.html April 3, 2009
Ranbaxy Laboratories (Gurgaon, India) says that the U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA; London) and Australia’s drug regulatory body...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Australia-U-K-Authorities-Okay-Ranbaxys-Indian-Plant_18032.html March 23, 2009
Biopharmaceutical company Cevec Pharmaceuticals (Cologne) says it has launched Cevec Amniocyte Production Technology (CAP-T), a transient expression system for fast, serum-free...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Cevec-Launches-New-Technology_17759.html March 23, 2009
Cambrex Karlskoga, a unit of Cambrex, has opened a previously announced $20-million active pharmaceutical ingredient (API) facility at Karlskoga, Sweden. The cGMP facility, which took...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Cambrex-Opens-API-Unit-in-Sweden_17758.html March 22, 2009
The U.S. Department of Justice (DOJ) has filed a lawsuit to block KV Pharmaceutical (St. Louis), its subsidiaries Ethex and Ther-Rx, as well as its principal officers from...http://www.chemweek.com/sections/pharma_and_fine_chemicals/DOJ-Sues-KV-Pharmaceutical-Over-Adulterated-Drug-Production_17757.html March 22, 2009
Merck & Co (Whitehouse Station, NJ) has agreed to acquire Schering-Plough (Kenilworth, NJ) for about $41.1 billion in stock and cash. The deal, which is expected to be completed in...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Merck-and-Co-to-Acquire-Schering-Plough-for-$41-Billion_17756.html March 19, 2009
Food ingredients giant Danisco has reported a loss of DK698 million ($123 million) for the company’s fiscal third quarter ended January 31. Corresponding sales were up 4% to...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Writedowns-Sour-Daniscos-Finances_17682.html March 12, 2009
Siegfried Holding (Zofingen, Switzerland), a mid-size fine chemicals contract manufacturer, has today announced the appointment of Rudolf Hanko as CEO. Hanko, 53 and a German citizen...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Evoniks-Hanko-Appointed-CEO-of-Siegfried-CFO-to-Depart_17586.html March 12, 2009
BASF says it is progressing well with its development of genetically engineered soybean species that are designed to be resistant to soybean rust, a fungus that has the potential to...http://www.chemweek.com/sections/pharma_and_fine_chemicals/BASF-Progresses-Rust-Prevention_17587.html March 9, 2009
China is the primary choice for pharmaceutical outsourcing, says a report by market data firm Research and Markets (Dublin). The Chinese pharmaceutical outsourcing industry has grown...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Chinese-Outsource-Market-Rises_17464.html March 6, 2009
The U.S. FDA has charged Ranbaxy Laboratories (Gurgaon, India) with falsifying data and test results in approved and pending drug applications at the company’s Paonta Sahib...http://www.chemweek.com/sections/pharma_and_fine_chemicals/FDA-Charges-Ranbaxy-with-Falsifying-Data-at-India-Plant_17461.html March 6, 2009
Lonza says it has entered into an agreement with drug developer Opsona Therapeutics (Dublin) to produce Opsona’s monoclonal antibody OPN-305. The agreement calls for Lonza to...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Lonza-to-Produce-Monoclonal-Antibodies-for-Opsona-Therapeutics_17462.html March 6, 2009
Indian pharmaceutical company Piramal Healthcare (Mumbai), formerly known as Nicholas Piramal, says it has completed the acquisition of Minrad International (Orchard Park, NY) for...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Piramal-Acquires-U-S-Firm_17463.html February 27, 2009
Bayer Schering Pharma, a Bayer subsidiary, says it will invest €100 million during the next five years to establish a global R&D center at Beijing. China will be the...http://www.chemweek.com/sections/pharma_and_fine_chemicals/Bayer-Schering-Pharma-to-Set-Up-R-and-D-Center-in-China_17310.html |
|
Connect with IHS Chemical Week |
Quick links |
Our related sites |
|
contact us | about us |
customer care |
privacy policy |
sitemap |
advertise
|
Follow us on Twitter
